CSBR
Champions Oncology Inc
4.90$
-1.0%
vs. previous close
Closing price · As of: Sep 25, 2026
Statements
Cash Flow
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | – | – | – | – | +56.0% | -157.9% | – | -39.1% | -255.2% | – | -160.5% | |
| – | -27.1% | +7.7% | +114.3% | +68.3% | +36.1% | +43.5% | +37.4% | +38.0% | -16.9% | -12.2% | -16.0% | |
| – | -17.8% | +2.4% | -62.3% | -36.7% | -5.7% | -0.3% | +52.5% | -5.3% | +29.4% | -41.5% | +89.1% | |
| – | -3.6% | +2.1% | -46.8% | -50.9% | +62.7% | -16.4% | +23.7% | +55.5% | – | – | – | |
| – | +169.8% | +0.2% | -233.7% | – | +22,554.5% | -267.3% | – | +81.6% | -190.1% | – | – | |
| – | +170.6% | +137.9% | +60.4% | -32.1% | +166.2% | +47.8% | -27.3% | +20.5% | -70.9% | -53.5% | +45.0% | |
| – | +182.5% | +137.9% | +60.1% | -32.0% | +166.2% | +42.7% | -24.8% | +20.5% | -70.9% | -53.5% | +38.8% | |
| – | – | – | – | – | – | – | – | – | – | – | – | |
| – | +2,100.0% | +9,763.6% | -99.1% | +3,755.3% | +204.1% | -69.3% | -84.9% | -135.7% | +756.8% | -100.0% | – | |
| – | -101.2% | +0.0% | +4.2% | +948.0% | -86.6% | +397.1% | -100.0% | – | – | +2.7% | -10.0% | |
| – | -100.0% | +215,700.0% | -99.7% | +9,153.8% | +267.4% | -73.0% | -82.7% | -94.7% | -4,890.9% | – | -41.8% | |
| – | -295.4% | – | -443.5% | – | +128.8% | -171.6% | – | -74.3% | -775.1% | – | -168.6% | |
| – | – | – | – | – | -33.4% | -824.4% | – | -73.7% | -743.9% | – | -172.0% |
Data as of: September 25, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.